封面
市場調查報告書
商品編碼
1649510

腦保護系統市場:預測(2025-2030 年)

Cerebral Protection System Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

大腦保護系統市場預計將從 2025 年的 1,033,241,000 美元成長到 2030 年的 1,528,241,000 美元,預測期內的複合年成長率為 8.14%。

全球腦保護系統 (CPS) 市場是一個快速擴展且充滿活力的行業,應用於醫學研究、診斷和藥物開發。腦保護系統,也稱為細胞表面抗原或分化標誌簇,是位於細胞外表面充當識別標籤的蛋白質或分子。這些標記物被廣泛用於識別、分離和表徵各種細胞群,有助於闡明細胞功能和疾病發病機制,並可能確定未來的治療目標。市場的成長受到多種因素的推動,包括慢性病盛行率的上升、自訂治療需求的增加、流式細胞技術和其他細胞分析技術的進步以及研發活動的投資活性化。

腦保護系統市場促進因素

  • 心血管疾病的增加:心血管疾病,尤其是主動脈瓣狹窄的發生率不斷上升,推動了腦保護系統的需求激增。主動脈瓣狹窄的特徵是主動脈瓣變窄,是老化人口的嚴重問題。這種情況通常需要手術干預,例如經導管主動脈瓣置換術(TAVR),但有導致腦栓塞的風險。因此,對能夠降低此類程序流程中風險的 CPS 的需求日益增加。

隨著老年人口的增加,與老齡化相關的心血管疾病的發生率也隨之增加。許多老年人是 TAVR 等微創手術的理想人選,人們對主動脈瓣狹窄相關併發症的擔憂也日益增加。這導致對 CPS 的需求增加,以確保這些手術過程中的病人安全。

地理視角

  • 亞太地區的快速成長:亞太地區的腦保護系統市場正在經歷顯著成長。主動脈瓣狹窄和冠狀動脈疾病等心血管疾病的流行持續推動該地區介入手術的增加。經導管主動脈瓣植入術 (TAVI) 等手術通常利用 CPS 來降低手術過程中發生栓塞事件的風險。

亞太地區的醫院採用先進的醫療技術旨在改善病患的治療效果。將 CPS 整合到心血管護理中表明了對提高患者安全性和降低與這些干預相關的中風和其他神經系統併發症的發生率的決心。

為什麼要購買這份報告?

  • 深刻分析:獲得深入的市場洞察,涵蓋主要和新興地區,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局:了解全球主要企業所採用的策略策略,並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力做出策略決策,在動態環境中開闢新的業務流和收益。
  • 適合廣泛用戶:對於新興企業、科學研究機構、顧問公司、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途?

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 各細分市場及各地區(包括國家)的收益成長及預測分析
  • 公司概況(策略、產品、財務、主要發展等)

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章 腦保護系統市場按類型

  • 介紹
  • 近端過濾器
  • 遠端過濾器
  • 導管

第6章 腦保護系統市場(依產品分類)

  • 介紹
  • 紅酒哨兵系統
  • Keystone Hearts 三重守護裝置
  • Emberla 栓塞導流器

第7章 腦保護系統市場按應用

  • 介紹
  • 醫院
  • 其他

8. 腦保護系統市場(按地區)

  • 介紹
  • 北美洲
    • 按類型
    • 按產品
    • 按應用
    • 按國家
  • 南美洲
    • 按類型
    • 按產品
    • 按應用
    • 按國家
  • 歐洲
    • 按類型
    • 按產品
    • 按應用
    • 按國家
  • 中東和非洲
    • 按類型
    • 按產品
    • 按應用
    • 按國家
  • 亞太地區
    • 按類型
    • 按產品
    • 按應用
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Boston Scientific Corporation
  • Medtronics
  • Edwards Lifesciences
  • InspireMD Inc.
  • Cardiovascular Systems Inc.
  • Kalert
  • Cordis
  • Allium Medical Inc
  • Keystone Heart Ltd
  • NeuroSafe Medical Co. Ltd.
  • Lepu Medical Technology Company
  • Gore Medical
  • Cardinal Health
  • Allium Medica
  • Abbot Laboratories
簡介目錄
Product Code: KSI061617274

The cerebral protection system market is projected to grow at a CAGR of 8.14% over the forecast period, increasing from US$1,033.241 million in 2025 to US$1,528.241 million by 2030.

The global cerebral protection system (CPS) market is a rapidly expanding and dynamic sector with applications in medical research, diagnostics, and drug development. Cerebral protection systems, also referred to as cell surface antigens or clusters of differentiation markers, are proteins or molecules located on the outer surface of cells that serve as identifying tags. These markers are widely used for identifying, isolating, and characterizing various cell populations, which aids in understanding cell function and disease causation, potentially identifying targets for future therapies. The market's growth is driven by several factors, including the rising prevalence of chronic diseases, increasing demand for custom therapies, advancements in flow cytometry and other cell analysis techniques, and heightened investment in research and development activities.

Drivers of the Cerebral Protection System Market

  • Rising Incidence of Cardiovascular Diseases: The demand for cerebral protection systems has surged due to the increasing prevalence of cardiovascular diseases, particularly aortic stenosis. Aortic stenosis is characterized by the narrowing of the aortic valve, which becomes a significant concern as the population ages. This condition often necessitates surgical interventions such as Transcatheter Aortic Valve Replacement (TAVR), which carry the risk of embolism to the brain. Consequently, there is a growing need for CPS to mitigate these risks during such procedures.

As the elderly population increases, so does the incidence of age-related cardiovascular diseases. Many older individuals are ideal candidates for minimally invasive procedures like TAVR, which raises concerns about complications associated with aortic stenosis. This has led to heightened demand for CPS to ensure patient safety during these interventions.

Geographical Outlook

  • Exponential Growth in Asia Pacific: The Asia Pacific region is experiencing significant growth in the cerebral protection systems market. The prevalence of cardiovascular disorders such as aortic stenosis and coronary artery disease continues to drive an increase in intervention procedures within this region. Procedures like Transcatheter Aortic Valve Implantation (TAVI) commonly utilize CPS to reduce the risk of embolic events during surgery.

The adoption of advanced medical technologies in hospitals across Asia Pacific aims to enhance patient outcomes. The integration of CPS into cardiovascular therapies demonstrates a commitment to improving patient safety and decreasing the incidence of stroke and other neurological complications associated with these interventions.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Cerebral protection system market is segmented and analyzed as follows:

By Type

  • Proximal filter
  • Distal filter
  • Catheter

By Product

  • Clarets Sentinel System
  • Keystone Hearts Triguard Device
  • Umbrella Embolic Deflector

By Application

  • Hospitals
  • Homes
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CEREBRAL PROTECTION SYSTEM MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Proximal filter
  • 5.3. Distal filter
  • 5.4. Catheter

6. CEREBRAL PROTECTION SYSTEM MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Clarets Sentinel System
  • 6.3. Keystone Hearts Triguard Device
  • 6.4. Embrella Embolic Deflector

7. CEREBRAL PROTECTION SYSTEM MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Homes
  • 7.4. Others

8. CEREBRAL PROTECTION SYSTEM MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Product
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. UK
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Product
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Product
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Medtronics
  • 10.3. Edwards Lifesciences
  • 10.4. InspireMD Inc.
  • 10.5. Cardiovascular Systems Inc.
  • 10.6. Kalert
  • 10.7. Cordis
  • 10.8. Allium Medical Inc
  • 10.9. Keystone Heart Ltd
  • 10.10. NeuroSafe Medical Co. Ltd.
  • 10.11. Lepu Medical Technology Company
  • 10.12. Gore Medical
  • 10.13. Cardinal Health
  • 10.14. Allium Medica
  • 10.15. Abbot Laboratories